Page 23 - Bio Engineering Approaches to Cancer Diagnosis and Treatment
P. 23
20 CHAPTER 1 Introduction
[6] P.J. Lachmann, Tumour immunology: a review, J. R. Soc. Med. 77 (12) (1984) 1023–
1029.
[7] P. Friedl, S. Alexander, Cancer invasion and the microenvironment: plasticity and reci-
procity, Cell 147 (5) (2011) 992–1009.
[8] F. Li, B. Tiede, J. Massagué, Y. Kang, Beyond tumorigenesis: cancer stem cells in metas-
tasis, Cell Res. 17 (1) (2007) 3–14.
[9] M. Shackleton, F. Vaillant, K.J. Simpson, J. Stingl, G.K. Smyth, M.L. Asselin-Labat, L.
Wu, G.J. Lindeman, J.E. Visvader, Generation of a functional mammary gland from a
single stem cell, Nature 439 (7072) (2006) 84–88.
[10] C.F. Kim, E.L. Jackson, A.E. Woolfenden, S. Lawrence, I. Babar, S. Vogel, D. Crowley,
R.T. Bronson, T. Jacks, Identification of bronchioalveolar stem cells in normal lung and
lung cancer, Cell 121 (6) (2005) 823–835.
[11] T. Miyamoto, I.L. Weissman, K. Akashi, AML1/ETO-expressing nonleukemic stem cells
in acute myelogenous leukemia with 8;21 chromosomal translocation, Proc. Natl. Acad.
Sci. U. S. A. 97 (13) (2000) 7521–7526.
[12] A.L. Welm, S. Kim, B.E. Welm, J.M. Bishop, MET and MYC cooperate in mammary
tumorigenesis, Proc. Natl. Acad. Sci. U. S. A. 102 (12) (2005) 4324–4329.
[13] J. Houghton, C. Stoicov, S. Nomura, A.B. Rogers, J. Carlson, H. Li, X. Cai, J.G. Fox,
J.R. Goldenring, T.C. Wang, Gastric cancer originating from bone marrow-derived cells,
Science 306 (5701) (2004) 1568–1571.
[14] S. Jaiswal, D. Traver, T. Miyamoto, K. Akashi, E. Lagasse, I.L. Weissman, Expression
of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias, Proc. Natl.
Acad. Sci. U. S. A. 100 (17) (2003) 10002–10007.
[15] L. Li, W.B. Neaves, Normal stem cells and cancer stem cells: the niche matters, Cancer
Res. 66 (9) (2006) 4553–4557.
[16] L. Harrington, Does the reservoir for self-renewal stem from the ends?, Oncogene 23 (43)
(2004) 7283–7289.
[17] J. Houghton, A. Morozov, I. Smirnova, T.C. Wang, Stem cells and cancer, Semin. Cancer
Biol. 17 (3) (2007) 191–203.
[18] P.M. Biggs, Oncogenesis and herpes virus II, Part 2, in: G. de The, M.A. Epstein, H. zur
Hausen (Eds.), Epidemiology, Host Response and Control II, IARC Publications, Lyon,
1972, pp. 317.
[19] R.T. Prehn, The immune reaction as a stimulator of tumor growth, Science 176 (4031)
(1972) 170–171.
[20] S.I. Schlager, S.H. Ohanian, T. Borsos, Correlation between the ability of tumor cells to
resist humoral immune attack and their ability to synthesize lipid, J. Immunol. 120 (2)
(1978) 463–471.
[21] A. Bleyer, A. Viny, R. Barr (Eds.), Cancer Epidemiology in Older Adolescents and Young
Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000, Na-
tional Cancer Institute, Bethesda, 2006 NIH Pub. No. 06-5767.
[22] M.F. Greaves, Analysis of the clinical and biological signify cance of lymphoid pheno-
types in acute leukemia, Cancer Res. 41 (11 Pt 2) (1981) 4752–4766.
[23] J.R. Wilczynski, M. Duechler, How do tumors actively escape from host immunosurveil-
lance?, Arch. Immunol. Ther. Exp. (Warsz.) 58 (6) (2010) 435–448.
[24] M. Lewis, G. Lewis, Strengthen the body and its immune cells, in: M. Lewis, G. Lewis
(Eds.), Cancer—A Threat to Your Life OR A Chance to Control Your Future, Australia
Cancer & Natural Therapy Foundation of Australia; Lewis Publications, New Zealand,
2006.